Probucol as an antioxidant and antiatherogenic drug
- 31 January 1993
- journal article
- review article
- Published by Elsevier in Free Radical Biology & Medicine
- Vol. 14 (1), 67-77
- https://doi.org/10.1016/0891-5849(93)90510-2
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- Protective role of intracellular glutathione against oxidized low density lipoprotein in cultured endothelial cellsBiochemical and Biophysical Research Communications, 1989
- Beyond CholesterolNew England Journal of Medicine, 1989
- Multiple receptors for modified low density lipoproteins in mouse peritoneal macrophages: Different uptake mechanisms for acetylated and oxidized low density lipoproteinsBiochemical and Biophysical Research Communications, 1989
- Effect of probucol on development of diabetes mellitus in BB ratsThe American Journal of Cardiology, 1988
- Free radical modification of low-density lipoprotein: Mechanisms and biological consequencesFree Radical Biology & Medicine, 1987
- Long-term use of probucol in the multifactorial primary prevention of vascular diseaseThe American Journal of Cardiology, 1986
- Effects of combined probucol-colestipol treatment for familial hypercholesterolemia and coronary artery diseaseThe American Journal of Cardiology, 1986
- Effects of probucol on xanthomata regression in familial hypercholesterolemiaThe American Journal of Cardiology, 1986
- Enhancement of recovery of myocardial function by oxygen free-radical scavengers after reversible regional ischemia.Circulation, 1985
- Summary estimates of cholesterol used to predict coronary heart disease.Circulation, 1983